Effectiveness of including homocysteine screening in cardiovascular risk management for older people: a pilot study

Completed

• Conditions: cardiovascular disease; heart disease; 10011082; 10003216

• Registration Number: NL-OMON34368
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Primary care patients 75 years and older without previous cardiovascular disease or diabetes who consult their general practitioner about their cardiovascular risk.

Exclusion Criteria

Exclusion criteria consists of patients with previous cardiovascular disease or diabetes, terminally ill patients and a diagnosis of dementia or cognitive impairment.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study endpoints are the number of patients that consult their general<br /><br>practitioner about their cardiovascular risk when a consultation like this is<br /><br>offered and the number of patients<br /><br>a. using cardiovascular preventive medication and high HCY;<br /><br>b. using cardiovascular preventive medication and low HCY;<br /><br>c. not using cardiovascular preventive medication and high HCY;<br /><br>d. not using cardiovascular preventive medication and low HCY).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Other study parameters would be the baseline values of the preventive consult,<br /><br>like age, gender, compliance with cardiovascular preventive medication,<br /><br>cholesterol and blood pressure and the anonymous demographical characteristics<br /><br>of the patients that attend the cardiovascular prevention consult ant those<br /><br>that did not. </p><br>